Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
2002 3
2003 4
2004 2
2005 4
2006 14
2007 15
2008 12
2009 9
2010 18
2011 19
2012 20
2013 25
2014 19
2015 13
2016 12
2017 18
2018 13
2019 18
2020 10
2021 20
2022 15
2023 19
2024 9

Text availability

Article attribute

Article type

Publication date

Search Results

268 results

Results by year

Filters applied: . Clear all
Page 1
Alpha-galactosylceramide improves the potency of mRNA LNP vaccines against cancer and intracellular bacteria.
Meulewaeter S, Aernout I, Deprez J, Engelen Y, De Velder M, Franceschini L, Breckpot K, Van Calenbergh S, Asselman C, Boucher K, Impens F, De Smedt SC, Verbeke R, Lentacker I. Meulewaeter S, et al. Among authors: de smedt sc. J Control Release. 2024 Apr 30:S0168-3659(24)00281-5. doi: 10.1016/j.jconrel.2024.04.052. Online ahead of print. J Control Release. 2024. PMID: 38697317
Nanomedicine to aid immunogenic cell death (ICD)-based anticancer therapy.
Demuynck R, Engelen Y, Skirtach AG, De Smedt SC, Lentacker I, Krysko DV. Demuynck R, et al. Among authors: de smedt sc. Trends Cancer. 2024 Mar 28:S2405-8033(24)00052-9. doi: 10.1016/j.trecan.2024.03.003. Online ahead of print. Trends Cancer. 2024. PMID: 38553361
Selective Replacement of Cholesterol with Cationic Amphiphilic Drugs Enables the Design of Lipid Nanoparticles with Improved RNA Delivery.
Bogaert B, Debisschop A, Ehouarne T, Van Eeckhoutte HP, De Volder J, Jacobs A, Pottie E, De Rycke R, Crabbé A, Mestdagh P, Lentacker I, Brusselle GG, Stove C, Verstraelen S, Maes T, Bracke KR, De Smedt SC, Raemdonck K. Bogaert B, et al. Among authors: de smedt sc. Nano Lett. 2024 Mar 13;24(10):2961-2971. doi: 10.1021/acs.nanolett.3c03345. Epub 2024 Mar 4. Nano Lett. 2024. PMID: 38477058
Non-viral delivery of RNA for therapeutic T cell engineering.
Berdecka D, De Smedt SC, De Vos WH, Braeckmans K. Berdecka D, et al. Among authors: de smedt sc. Adv Drug Deliv Rev. 2024 May;208:115215. doi: 10.1016/j.addr.2024.115215. Epub 2024 Feb 23. Adv Drug Deliv Rev. 2024. PMID: 38401848 Review.
Laser-induced vapor nanobubbles for B16-F10 melanoma cell killing and intracellular delivery of chemotherapeutics.
Ramon J, Engelen Y, De Keersmaecker H, Goemaere I, Punj D, Mejía Morales J, Bonte C, Berx G, Hoste E, Stremersch S, Lentacker I, De Smedt SC, Raemdonck K, Braeckmans K. Ramon J, et al. Among authors: de smedt sc. J Control Release. 2024 Jan;365:1019-1036. doi: 10.1016/j.jconrel.2023.12.006. Epub 2023 Dec 22. J Control Release. 2024. PMID: 38065413
Considerations on the Design of Lipid-based mRNA Vaccines Against Cancer.
Meulewaeter S, Zhang Y, Wadhwa A, Fox K, Lentacker I, Harder KW, Cullis PR, De Smedt SC, Cheng MHY, Verbeke R. Meulewaeter S, et al. Among authors: de smedt sc. J Mol Biol. 2024 Jan 15;436(2):168385. doi: 10.1016/j.jmb.2023.168385. Epub 2023 Dec 6. J Mol Biol. 2024. PMID: 38065276 Review.
268 results